Donor Surgical Morbidity in Pediatric Living-Donor Liver Transplant: A Portuguese Experience
10.5223/pghn.2021.24.6.528
- Author:
José Pedro Fernandes dos SANTOS
1
;
Ricardo MARTINS
;
Maria Francelina LOPES
Author Information
1. University of Coimbra, Faculty of Medicine, Coimbra, Portugal
- Publication Type:Original Article
- From:Pediatric Gastroenterology, Hepatology & Nutrition
2021;24(6):528-534
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:Living-donor liver transplant emerged as an alternative treatment for end stage liver disease due to the lack of cadaveric organs availability that met the demand. In Portugal, pediatric living-donor liver transplant (P-LDLT) was initiated in 2001 in Portugal in order to compensate for the scarcity of cadaveric organs for such cases. The aim of this study was to retrospectively analyze the morbi-mortality of the 28 donors included in P-LDLT program performed at Coimbra's Pediatric Hospital (CHUC), a Portuguese reference center.
Methods:We retrospectively collected pertinent donor data and stratified complications according to Clavien's scoring system.
Results:In total, 28.6% (n=8) of the donors had surgical complications. According to Clavien-Dindo's classification, two donors had major complications (Clavien grade ≥3), four donors had grade 2 complications, and two donors had grade 1 complications. There were no P-LDLT-related mortalities in the present case series. The most common verified complications were biliary tract injuries and superficial incisional infections, which are consistent with the complications reported in worldwide series.
Conclusion:These patients from CHUC shows that donor hepatectomy in P-LDLT is a safe procedure, with low morbidity and without mortality.
